September 14, 2016

After Setbacks, a Pioneering Stem-Cell Technology’s Back in Human Trials

(MIT Technology Review) – A company that stepped in to salvage the first-ever medical use of human embryonic stem cells says it has encouraging results in patients with spinal-cord injury. Today, Asterias Biotherapeutics, the company in Fremont, California, that’s developing the … Read More

Recommended Reading